美国药物过敏登记处 (USDAR) 对即时药物反应的分级
David A Khan1, Elizabeth J Phillips2, John J Accarino3
1Department of Internal Medicine, Division of Allergy and Immunology, University of Texas Southwestern Medical Center, Dallas, Tex.
The Journal of allergy and clinical immunology
|August 31, 2023
概括
药物过敏专家提出了一种针对即时药物反应的新分级系统. 该系统将反应严重程度从0到4进行分类,以帮助临床护理和研究.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 对于即时药物反应,没有普遍接受的分级系统.
- 这种缺乏标准化阻碍了一致的临床评估和研究.
研究的目的:
- 引入一种新的,基于共识的等级系统,用于即时药物反应.
- 由美国药物过敏登记 (USDAR) 联盟的专家开发.
主要方法:
- 美国DAR调查人员采用了基于共识的方法.
- 该系统旨在在临床实践和研究环境中适用.
主要成果:
- 对于即时药物反应,建立了从0到4的严重程度等级.
- 0级表示没有反应或轻微的主观症状,这表明过敏的可能性很低.
- 1-4级表示积极的挑战结果,4级代表危及生命的反应,如过敏性休克.
结论:
- 拟议的USDAR分级方案为分类即时药物反应提供了一种标准化的方法.
- 它的特殊设计,即时反应和易于实施,提高了临床和研究的实用性.
关键词:
药物过敏 药物过敏 药物过敏美国美元美元美元.这是一种β-lactam.一致的共识共识.毒品挑战 毒品挑战药物挑测试试验 药物挑测试药物反应 药物反应一个分级的挑战.评分分级的评分分级.立即的过敏性过敏.这种青素是青素.严重程度的严重程度.皮肤测试 皮肤测试试验剂量测试剂量更多相关视频
相关概念视频
Pharmacovigilance
886
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
886
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Nomenclature
1.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.8K
Dose-Response Relationship: Potency and Efficacy
4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
Dose-Response Relationship: Selectivity and Specificity
6.9K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.9K
SBAR II: Application of SBAR
4.5K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.5K


